Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Allergy to cats : current perspectives and therapeutic options

Title: Allergy to cats : current perspectives and therapeutic options
Authors: Demoly, Pascal; Zakariya, Myriam; Dávila, Ignacio; Scibilia, Giuseppe; Ortolani, Valeria; Domínguez‐Ortega, Javier; Bergmann, Karl‐Christian; Gevaert, Philippe; Didier, Alain
Source: CLINICAL AND TRANSLATIONAL ALLERGY ; ISSN: 2045-7022
Publication Year: 2026
Collection: Ghent University Academic Bibliography
Subject Terms: Medicine and Health Sciences; allergen immunotherapy; allergic rhinitis; asthma; cat allergy; Fel d 1; VIRUS-LIKE PARTICLES; DOG-DANDER EXTRACTS; DOUBLE-BLIND; FURRY ANIMALS; SUBLINGUAL IMMUNOTHERAPY; INHALANT ALLERGENS; SKIN-TEST; SENSITIZATION
Description: Allergic rhinitis (AR) and asthma caused by cat dander have a highly variable prevalence across countries, which can reach 30% of the population in some regions. Cat allergens are widely distributed in the environment, making exposure nearly unavoidable, even in non-cat-owning households. Eight cat allergens have been identified, with Fel d 1 and Fel d 4 being particularly associated with the development and severity of asthma. Symptoms can range from mild nasal and eye symptoms to severe asthma exacerbations, with many patients experiencing polysensitization to other allergens. Management usually begins with allergen avoidance and pharmacotherapy, but these approaches are often insufficient. Allergen immunotherapy (AIT), both sublingual (SLIT) and subcutaneous (SCIT), offers a disease-modifying strategy, though allergen potency, composition, standardization issues, and low prescription rates limit its use. AIT formulations that include allergens beyond Fel d 1, such as Fel d 4, show promise in improving cat-induced asthma and rhinitis outcomes. Additionally, novel approaches for antigen presentation or combination therapies with monoclonal antibodies may enhance the effectiveness and safety of AIT. To increase treatment success, personalized care using component-resolved diagnostics to identify sensitization profiles and better education for both physicians and patients are essential in the broader adoption of cat AIT.
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
Relation: https://biblio.ugent.be/publication/01KM56CMYGXFCXV9X8YNBFB1GX; https://doi.org/10.1002/clt2.70152; https://biblio.ugent.be/publication/01KM56CMYGXFCXV9X8YNBFB1GX/file/01KMJHATW1KVBX3W8BJZAS4FD5
DOI: 10.1002/clt2.70152
Availability: https://biblio.ugent.be/publication/01KM56CMYGXFCXV9X8YNBFB1GX; https://hdl.handle.net/1854/LU-01KM56CMYGXFCXV9X8YNBFB1GX; https://doi.org/10.1002/clt2.70152; https://biblio.ugent.be/publication/01KM56CMYGXFCXV9X8YNBFB1GX/file/01KMJHATW1KVBX3W8BJZAS4FD5
Rights: info:eu-repo/semantics/openAccess
Accession Number: edsbas.500EF484
Database: BASE